Hiperdia S.A.
- Address
- Soseaua Oltenitei Sector 4 Nr 87-99, 041312 Bucharest, Romania
Hiperdia S.A. - Immunology and Cardiovascular Research Center
Hiperdia S.A. is a specialized medical research center focused on advancing therapeutic interventions for immune-mediated inflammatory diseases and cardiovascular conditions. The center demonstrates expertise in conducting Phase II and III clinical trials evaluating novel biologic and pharmacological agents for complex chronic diseases requiring long-term management strategies.
- Psoriatic Arthritis and biologic DMARD therapies including sonelokimab treatment protocols
- Systemic Lupus Erythematosus (SLE) with focus on novel immunomodulatory agents like deucravacitinib
- Chronic Stable Angina Pectoris and anti-anginal therapeutic interventions
The research portfolio at Hiperdia S.A. reflects a commitment to addressing both autoimmune rheumatologic disorders and cardiovascular disease, with particular emphasis on evaluating efficacy and safety outcomes in biologic-naive patient populations. The center's experience spans from evaluating targeted biologic therapies for inflammatory arthropathies to assessing cardiovascular interventions for ischemic heart disease manifestations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Janssen Cilag International2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International3trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hiperdia S.A.
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults with Systemic Sclerosis | Zura Bio Inc. | Phase II | Not Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Litifilimab | 2 | Unknown | 2022-02-10 | 2022-06-10 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.